Cathie Wood Watch: Ark ទិញ Aerospace, ក្រុមហ៊ុនផលិតរថយន្តចិន; លក់ឱសថ

Star investor Cathie Wood, chief executive of Ark Investment Management, remains active in the tumultuous stock market, on Monday buying aerospace and Chinese-vehicle shares. She sold pharmaceutical stocks.

Ark funds purchased 817,817 shares of Archer Aviation (អេស៊ីអេអរ) , an electric taxi aircraft maker, which was valued at $2.4 million. (All valuations are as of Monday’s close.)

Cathie Wood Watch: Ark Buys Biotech, Electric-Air-Taxi Producer

បច្ចេកវិទ្យាស្វយ័តអាកទិកនិងរ៉ូបូតអេអេហ្វ (អាខេក) - ទទួលបានរបាយការណ៍ ARK Autonomous Technology & Robotics ETF bought 53,228 shares of China’s BYD (ប៊ីឌីឌី) , which makes electric cars, valued at $2.3 million.

As for the pharma selling, Ark Genomic Revolution ETF (អេខេខេជី) - ទទួលបានរបាយការណ៍ ARK Genomic Revolution ETF sold 59,043 shares of Pfizer (ភីអេហ្វអេស) - ទទួលបានរបាយការណ៍របស់ Pfizer Incដែលមានតម្លៃ ៧.៩៥ លានដុល្លារ។

Ark Genomic Revolution shed 4,785 shares of Regeneron (REGN) - ទទួលបានរបាយការណ៍ Regeneron Pharmaceuticals, Inc, valued at $3.1 million. And Ark Genomic unloaded 32,331 shares of Vertex Pharmaceuticals (អេសធីធី) - ទទួលបានរបាយការណ៍រួមបញ្ចូលឱសថ Vertexដែលមានតម្លៃ ៧.៩៥ លានដុល្លារ។

Cathie Wood Watch: Ark Seeks to 3D-Print Investing Profits

Wood last week offered an interesting take on oil prices, as they soared in reaction to Russia’s invasion of Ukraine.

She wrote on Twitter that she erred in 2020, when she said oil demand probably peaked in 2019 and prices were headed down to $12.

“I got the supply shock wrong,” Wood wrote. “That said, the accelerated shift toward electric transportation will destroy oil consumption at the margin. Long-term, though longer-term than I expected, oil prices will collapse under the weight of lower demand. Innovation solves problems!”

Source: https://www.thestreet.com/investing/cathie-wood-ark-buys-areospace-china-car-maker-sells-pharma?puc=yahoo&cm_ven=YAHOO&yptr=yahoo